A
Aldeyra Therapeutics, Inc. (ALDX)
NCM – Real vaqt narxi. Valyuta: USD
1.71
-0.05 (-2.84%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.71
+0.00 (0.19%)
Bozor oldidan: May 13, 2026, 4:58 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.71
-0.05 (-2.84%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.71
+0.00 (0.19%)
Bozor oldidan: May 13, 2026, 4:58 AM EDT
Aldeyra Therapeutics, Inc. biotexnologiya kompaniyasi bo'lib, immunitet vositachiligidagi kasalliklarni davolashga mo'ljallangan terapiyalarni kashf etadi va ishlab chiqadi. Uning asosiy mahsulot nomzodi reproksalap, reaktiv aldehid zarralari (RASP) modulyatori bo'lib, u quruq ko'z sindromi va allergik kon'yunktivitni davolash bo'yicha III bosqich klinik sinovlarida; va ADX-2191, birlamchi vitreoretinal limfoma va retinit pigmentozani davolash uchun dihidrofolat reduktaza ingibitori. Kompaniya, shuningdek, COVID-19, atopik astma, psoriaz va alkogol intoksikatsiyasini davolash bo'yicha II bosqich klinik sinovlarida bo'lgan og'iz orqali yuboriladigan RASP modulyatori bo'lgan ADX-629ni ishlab chiqadi. Bundan tashqari, u RASP bilan bog'liq turli kasalliklarni davolash uchun ADX 248, ADX 246 va boshqa yangi RASP modulyatorlarini o'z ichiga olgan klinik oldi RASP platformalarini ishlab chiqadi. Kompaniya ilgari Aldexa Therapeutics, Inc. nomi bilan tanilgan va 2014 yil mart oyida Aldeyra Therapeutics, Inc. nomini olgan. Aldeyra Therapeutics, Inc. 2004 yilda tashkil etilgan va Massachusets shtatining Lexington shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| David Burke | Head of Investor Relations |
| Dr. Adam Lazorchak | Director of Translational Sciences & Non-Clinical Development |
| Dr. Todd C. Brady M.D., Ph.D. | CEO, President & Director |
| Laura Nichols | Operations Manager |
| Mr. Michael Alfieri | Head of Finance and Principal Financial & Accounting Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 10-Q | aldx-20260331.htm |
| 2026-05-01 | 8-K | aldx-20260501.htm |
| 2026-04-27 | DEFA14A | d136169ddefa14a.htm |
| 2026-04-20 | 8-K | aldx-20260420.htm |
| 2026-04-01 | 8-K | aldx-20260401.htm |
| 2026-03-17 | 8-K | aldx-20260317.htm |
| 2026-02-27 | S-8 | d103363ds8.htm |
| 2025-12-31 | 8-K | d69806d8k.htm |
| 2025-12-16 | 8-K | aldx-20251215.htm |
| 2025-11-13 | 8-K | aldx-20251113.htm |